Lates News

According to AI Fast News, Pacific Securities issued a research report on August 28, giving a recommendation to increase holdings of Baicheng Pharmaceuticals (301096.SZ). The main reasons for the recommendation include: 1) Revenue is lower than expected, and profits are under pressure; 2) The year-on-year decline in revenue of various businesses, while the profitability of clinical business is improving; 3) Continuously strengthening the research and development team, optimizing the research and development project structure. (Daily Economic News)